Shanghai Hengrui Pharmaceutical competitive analysis

Explore Shanghai Hengrui Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 29, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jan 28, 2026Fused Imidazole Derivative, Preparation Method Therefor, And Medical Use Thereof1
May 27, 2020Il-15 Heterogeneous Dimer Protein And Uses Thereof1

Latest PTAB cases involving Shanghai Hengrui Pharmaceutical

Discover the latest PTAB cases involving Shanghai Hengrui Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Shanghai Hengrui Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SHANGHAI HENGRUI PHARMACEUTICAL - 2 - -
JAMES POOLE207 - - -
MARGARET DIXON67 - - -